Cargando…
Missing diversity in brain tumor trials
BACKGROUND: Clinical trials for brain tumors represent a significant opportunity for both patients and providers to understand and combat a disease with substantial morbidity. The aim of this study was to quantify and map ethnic and racial representation in brain tumor trials and examine the potenti...
Autores principales: | Taha, Birra, Winston, Graham, Tosi, Umberto, Hartley, Benjamin, Hoffman, Caitlin, Dahmane, Nadia, Mason, Christopher E, Greenfield, Jeffrey P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316223/ https://www.ncbi.nlm.nih.gov/pubmed/32642711 http://dx.doi.org/10.1093/noajnl/vdaa059 |
Ejemplares similares
-
An integrated disease-specific graded prognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation status
por: Ahluwalia, Manmeet, et al.
Publicado: (2020) -
Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors
por: Rajappa, Prajwal, et al.
Publicado: (2022) -
4565 Sex-Specific Differences in the Genomic Landscape of Pediatric and Adult Glioblastoma
por: Ivanov, Nikolay A., et al.
Publicado: (2020) -
Artificial neural networks predict the need for permanent cerebrospinal fluid diversion following posterior fossa tumor resection
por: Bray, David P, et al.
Publicado: (2022) -
Modified abdominal packing method in “near miss” patients with postpartum hemorrhages
por: Kılıççı, Çetin, et al.
Publicado: (2018)